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Abstract
Background: Although education, exercise, and weight loss are recommended for management of knee
osteoarthritis, the additional benefits of incorporating weight loss strategies into exercise interventions have not
been well investigated. The aim of this study is to compare, in a private health insurance setting, the clinical- and
cost-effectiveness of a remotely-delivered, evidence- and theory-informed, behaviour change intervention targeting
exercise and self-management (Exercise intervention), with the same intervention plus active weight management
(Exercise plus weight management intervention), and with an information-only control group for people with knee
osteoarthritis who are overweight or obese.
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Methods: Three-arm, pragmatic parallel-design randomised controlled trial involving 415 people aged ≥45 and ≤
80 years, with body mass index ≥28 kg/m2 and < 41 kg/m2 and painful knee osteoarthritis. Recruitment is Australia-
wide amongst Medibank private health insurance members. All three groups receive access to a bespoke website
containing information about osteoarthritis and self-management. Participants in the Exercise group also receive six
consultations with a physiotherapist via videoconferencing over 6 months, including prescription of a strengthening
exercise and physical activity program, advice about management, and additional educational resources. The
Exercise plus weight management group receive six consultations with a dietitian via videoconferencing over 6
months, which include a very low calorie ketogenic diet with meal replacements and resources to support
behaviour change, in addition to the interventions of the Exercise group. Outcomes are measured at baseline, 6 and
12 months. Primary outcomes are self-reported knee pain and physical function at 6 months. Secondary outcomes
include weight, physical activity levels, quality of life, global rating of change, satisfaction with care, knee surgery
and/or appointments with an orthopaedic surgeon, and willingness to undergo surgery. Additional measures
include adherence, adverse events, self-efficacy, and perceived usefulness of intervention components. Cost-
effectiveness of each intervention will also be assessed.
Discussion: This pragmatic study will determine whether a scalable remotely-delivered service combining weight
management with exercise is more effective than a service with exercise alone, and with both compared to an
information-only control group. Findings will inform development and implementation of future remotely-delivered
services for people with knee osteoarthritis.
Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN12618000930280 (01/06/2018).
Keywords: Osteoarthritis, Exercise, Telerehabilitation, Weight management, Ketogenic diet, Knee, Pain, Obesity, RCT,
Physiotherapy, Dietitian
Background
Knee osteoarthritis (OA) is a major public health prob-
lem [1] and incurs enormous indirect and direct health-
care costs [2]. All current clinical guidelines recommend
non-surgical non-drug treatments for first-line manage-
ment of OA, including education/advice, exercise, and, if
appropriate, weight loss [3, 4]. However, there is evi-
dence that a substantial proportion of people with OA
in Australia are not receiving recommended care [5].
For example, although surgery is only recommended for
those with severe symptomatic OA who do not respond
to conservative management approaches, data from an
Australian hospital found that 33% of people referred for
orthopaedic management had not engaged in any non-
drug conservative management methods [6]. From 2005
to 06 to 2015–16, Australia has seen a 38% rise in the
rate of total knee replacements for OA [7], yet 20% of
people undergoing knee replacement surgery report
unsatisfactory outcomes [8]. Given that the prevalence
of knee OA is projected to rise in the coming decades
[2, 9], there is an urgent need to increase uptake of
recommended conservative management options through
implementation of effective, accessible and scalable models
of service delivery.
The benefits of therapeutic exercise for people with
knee OA are well-established [10], with similar efficacy
to analgesics and non-steroidal anti-inflammatory drugs,
but with fewer side-effects [11, 12], and with fewer risks
than joint replacement surgery. Given that muscle
weakness is common amongst people with OA [13],
muscular strengthening exercises are important and can
help reduce pain, and improve physical function [14]. In
addition, as most people with OA do not meet physical
activity recommendations [15], advice to increase phys-
ical activity is also important. For example, research has
demonstrated that people with knee OA who are less
sedentary have better physical function, independent of
time spent doing moderate or vigorous physical activity
[16, 17], and that a threshold of 6000 steps per day
discriminates between people with knee OA who do and
do not develop functional limitations 2 years later [18].
Given that people with OA who are overweight or
obese tend to experience more severe symptoms [19, 20]
and are more likely to undergo joint replacement sur-
gery [21], weight loss is an important component of
management. However, although weight loss is recom-
mended by evidence-based guidelines [4, 22, 23] there is
only limited evidence to support its efficacy in improving
symptoms of pain and dysfunction. In the literature, in-
terventions often combine both exercise and weight loss
components, making it difficult to identify the independ-
ent effects of weight loss on outcomes. One pivotal trial
involving 454 overweight and obese adults with knee
OA investigated the effects of an intensive diet program,
with and without exercise, conducted in a rigorously
monitored environment [24]. The combined diet and ex-
ercise group lost approximately 10% of body weight,
compared to 2% in the exercise only group, leading to
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reduced knee loads and inflammation compared to the
exercise only group. While statistically significant bene-
fits on pain (1-point difference (95% confidence interval:
0.3 to 1.7) on 20-point scale) and function (4.3-point dif-
ference (2.1 to 6.5) on 68-point scale) were also seen, the
magnitude of these benefits are small and may be of ques-
tionable clinical importance. Furthermore, although the
diet and exercise intervention was reported to be more
cost-effective than usual care (pharmacological NSAIDs
regimen followed by total knee replacement surgery) [25],
the cost-effectiveness analyses did not include data from
the exercise only group. Thus, it remains unknown whether
a combined intervention of diet and exercise is more cost-
effective than exercise alone.
Although the findings of Messier and colleagues [24]
support the efficacy of combined weight loss and exer-
cise programs, their interventions were time-intensive
and potentially costly, with the weight loss component
involving 12 individual and 42 group sessions for nutri-
tion education and behavioural support over 18-months,
and the exercise component involving three group exer-
cise sessions per week for 6-months. Given that many
barriers to self-management of OA relate to inaccessibil-
ity and/or costs of healthcare [26, 27], implementation
of such an intensive program outside of a research
setting is likely to be difficult in most community or
hospital settings, either public or private, without con-
siderable cost and time burdens. Identifying effective
programs that minimise active involvement by clinicians
is therefore important. One way in which to improve the
accessibility and scalability of care is to provide it re-
motely via technology (telerehabilitation), allowing pa-
tients to consult from their own home or workplace.
There is emerging evidence that telerehabilitation for
people with musculoskeletal conditions improves pain
and function and is equivalent to outcomes following
traditional in-person consultations [28]. More recently,
there is evidence that exercise advice and prescription de-
livered by physiotherapists via videoconferencing leads to
improvements in pain and function in people with knee
OA [29]. Importantly, such a service is also acceptable to
both the people with knee pain receiving care and the
physiotherapists delivering it [30]. Similarly, dietary inter-
ventions for weight loss can also be effective when deliv-
ered remotely. A recent systematic review and meta-
analysis found that dietary interventions for people with
chronic diseases (i.e. obesity, diabetes, heart disease,
hypertension, stroke, or kidney disease) delivered by dieti-
tians or nurses via video or telephone improved diet qual-
ity and led to significant weight loss and reduced waist
circumference [31]. No previous studies have investigated
the effectiveness of remotely-delivered exercise and weight
management programs by physiotherapists and dietitians
for people with knee OA who are overweight or obese.
For many people with OA, undertaking an exercise
and/or weight management program requires consider-
able changes in lifestyle behaviours over prolonged pe-
riods of time. As such, it is important that intervention
development is underpinned by behaviour change the-
ory, and informed by best practice in chronic disease
management and self-management support programs.
Interventions must include provision of high quality in-
formation. However, education alone is insufficient to
support behavioural change. Healthcare clinicians must
also have the communication and psychosocial skills ne-
cessary to facilitate long-term changes in behaviour [32,
33]. Incorporating behavioural counselling [34, 35] and
specific behaviour change techniques that are effective
for supporting change in exercise and eating behaviours
in this population [36] into intervention design will fa-
cilitate participants to achieve and sustain effective self-
management practices in the long-term.
The aim of this study, conducted in a private health
insurance setting, is to compare the effectiveness of two
remotely-delivered, evidence- and theory-informed, be-
haviour change interventions to provide information and
behaviour change support for i) exercise and; ii) exercise
plus weight management, to each other, and to an
information-only control for people with knee OA who
are overweight or obese. We hypothesise that the exer-
cise plus weight management intervention will lead to
greater improvements in pain and function than the
exercise intervention and that both interventions will be
more effective than information only.
Methods/design
Design
The Better Knee, Better Me™ trial is a three-arm prag-
matic superiority parallel-design randomised controlled
trial. Figure 1 outlines the RCT phases. This protocol
has been developed according to the SPIRIT statement
[37]. The trial has been prospectively registered in the
Australian New Zealand Clinical Trials Registry (ACTR
N12618000930280). The trial is conducted at The Uni-
versity of Melbourne. The effectiveness and cost-
effectiveness of interventions will be assessed by analys-
ing a range of outcomes and reported as the main trial
results. Nested qualitative studies of participants’ and
clinicians’ experiences participating in the trial will be
used to explore the acceptability and usefulness of the
services, as well as explore the barriers and facilitators to
engagement. However, this will be reported separately to
the main trial results.
Participants
A total of 415 participants who have private health in-
surance with Medibank Private at a level that includes
cover for arthroplasty surgery are recruited from around
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Australia. Medibank Private is one of Australia’s largest
health funds, with 3.7 million members across Australia
[38]. Inclusion and exclusion criteria are outlined in
Table 1. Medibank Private send targeted invitations, pre-
dominantly via email, to potentially eligible members.
They also advertise the study in their member newslet-
ters and on their website. The University of Melbourne
manage the clinical screening of volunteers. Screening
occurs via a two-step process; i) via an online survey
and, if eligible, ii) via additional telephone screening by
research personnel at The University of Melbourne.
Additional clearance to participate is sought from a gen-
eral practitioner for anyone who does not pass pre-
exercise screening questions [40], reports more than 1
fall in the past 12 months, or is house-bound due to
mobility limitations (e.g. concurrent disabling low back
pain).
Data collection and management
Data are collected via online questionnaire and stored
on a secure password-protected server. The “study knee”
is the painful knee or, in people with bilaterally eligible
knees, the most painful knee.
Randomisation allocation concealment and blinding
The randomisation schedule is computer generated and
prepared by the study biostatistician. Following comple-
tion of the baseline questionnaire, participants are
Fig. 1 Participant flow through the randomized controlled trial
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randomly allocated to either the Exercise group, the Ex-
ercise plus weight management group, or the information
only (Control) group. Due to the differences expected to
be observed between treatment groups (effect size of
0.3) and between the least-performing treatment group
and the control group (effect size of 0.4), to minimise
the number of control group participants required, we
will recruit fewer participants in the control group than
in either treatment group: see details in the Trial sample
size section below. This leads to a randomisation ratio of
5:5:2 (for every 5 participants randomised to a treatment
group, we will only randomise 2 to the control group).
We expect to see a smaller difference between the two
treatment groups than between the least-performing
treatment group and the control group. Randomisation
will be stratified by history of knee surgery (arthroscopy
or contralateral arthroplasty). Participants allocated to
the Exercise group are randomly allocated to one of three
physiotherapists. Participants allocated to the Exercise plus
weight management group are randomly allocated to one
of the same three physiotherapists as in the Exercise
group, and one of five dietitians. If a physiotherapist or
dietitian is unavailable (e.g. sick, on holidays), participants
are re-randomised to another available clinician. To con-
ceal group allocation, a researcher not involved in partici-
pant recruitment accesses the randomisation schedule via
a password-protected computer program.
Given that all primary and secondary outcomes are self-
reported, participants are also the assessors. Participants
are blinded to study hypotheses, however the components
of each treatment arm are disclosed during recruitment.
This replicates real-world conditions whereby consumers
are fully informed about the nature of the treatment com-
ponents before choosing whether or not to participate/re-
ceive an intervention. Physiotherapists and dietitians are
not blinded to group allocation.
Information only (control) group
The information only (Control) group receive informa-
tion, advice, and education about OA and its manage-
ment via a bespoke website developed by the research
team which is only accessible via password login. The
website includes: i) educational information including
understanding OA, recommended treatment options (in-
cluding a total knee replacement decision aid), exercise
and physical activity, weight loss, understanding and
managing pain (including audio files to facilitate mini-
relaxations and pleasant imagery), sleep, and “success
stories” from other people with knee OA, and; ii) links
to recommended external websites for further help and
support (e.g. MyJointPain, painHEALTH, Musculoskel-
etal Australia). Participants have access to the study
website from enrolment to completion of the 12-month
follow-up questionnaire.
Intervention design
Design of the interventions is underpinned by the
Chronic Care model [41], recommendations for design
Table 1 Participant eligibility criteria
Inclusion criteria Exclusion criteria
Fulfil National Institute for Health and Care Excellence [3] clinical criteria
for osteoarthritis:
• Age > 45 years;
• Have activity related joint pain; and
• Have morning stiffness ≤30min.
Average knee pain severity ≥4 on 11-point numeric rating scale (NRS,
where 0 = no pain, 10 = worst pain possible) in the past week
History of knee pain on most days for at least 3 months
Aged < 81 years – due to potential safety reasons and additional co-
morbidities
Body mass index (BMI) ≥ 28 kg/m2 and < 41 kg/m2. The lower BMI limit
was chosen according to recommendations [39] that VLCD are effective
in supporting weight loss in people with a BMI > 27. The upper limit was
chosen as these individuals often require more extensive intervention
and for possible safety reasons
Member of Medibank with a level of cover that includes arthroplasty
surgery
Able to give informed consent and to participate fully in the
interventions and assessment procedures
Willing to follow advice for self-management, participate in exercise/phys-
ical activity and/or participate in a weight loss program if part of their
treatment program
Have the ability to weigh themselves (e.g. have access to the same set of
bathroom scales)
Booked for knee surgery on either knee
Have had all eligible knee joints replaced by arthroplasty
Knee surgery within the past 6 months
Unable to speak or read English
Self-reported diagnosis of rheumatoid arthritis or other inflammatory
arthritis
Other medical condition or upcoming medical procedures that in the
opinion of the research staff and/or investigators would preclude
participation
Private health insurance claims related to cancer treatment or inpatient
neurological rehabilitation in the previous 12months, palliative care, or
acquired brain injury
Unable to use/access a telephone and internet
For those identified as at risk from the pre-exercise and falls screening,
doctor does not give clearance
Used low-calorie meal replacement products (e.g. Optifast/Optislim) for
weight loss in previous 6 months
Currently, or in the past 6 months, undertaking regular strengthening
exercises for the knee
Unable to undertake VLCD for medical reasons including:
i. Self-reported diagnosis of Type 1 diabetes
ii. Self-reported Type 2 diabetes requiring insulin or other medication
apart from metformin
iii. Self-reported warfarin use
iv. Stroke or cardiac event in previous 6 months
v. Unstable heart condition
vi. Fluid intake restriction
BMI Body mass index, VLCD Very low calorie diet
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and evaluation of self-management support programs
[33], and the information-motivation-behavioural skills
theoretical model (IMB) for behaviour change [42, 43].
The Chronic Care model [41] explains the importance
of productive interactions between clinicians with the
right skills and patients who are informed and activated.
An intervention with the aim of facilitating effective self-
management by patients must both activate and then
support patient behaviour change. The IMB model con-
tends that although information is a pre-requisite for
change, on its own information will not activate change
[44]. The model explains that having the motivation to
change, and the behavioural skills needed in order to
change, are independent and essential determinants [43].
Other interventions based on this model have been effect-
ive in influencing behavioural change across a variety of
clinical applications [45]. This model of change is consist-
ent with the recommendation that in order to be effective,
self-management support programs must include moti-
vational coaching interventions as well as educational
interventions that link knowledge with skills [33].
Two recent systematic reviews support the effective-
ness of coaching interventions, such as Motivational
Interviewing, for managing chronic conditions [35] and
chronic painful musculoskeletal conditions [34], specific-
ally in regard to increasing physical activity behaviours.
Coaching from clinicians must be patient-centred and
tailored to the needs and concerns of the individual [33].
Training and protocols for the clinicians are important
intervention components, especially since these coaching
skills are not often taught during entry to practice train-
ing for health professionals and both clinicians and
trainees report skills deficits in this area [46]. In addition
to being able to effectively deliver high quality informa-
tion to facilitate desired behaviour change, clinicians also
need to incorporate specific behaviour change tech-
niques such as shared decision-making, goal setting,
problem solving, confidence building, review and
reinforcement. Additional techniques that have been
shown to be effective for supporting change in exercise
and eating behaviours and that are included in the inter-
ventions include providing information about the conse-
quences of the behaviour, encouraging social support,
phased action planning, self-monitoring, graded tasks,
reinforcing successful behaviour, prompting focus on
past success, providing feedback about the participant’s
behaviour, barrier identification, and relapse prevention/
coping planning [36].
The intervention design is additionally based on best
practice recommendations for management of knee OA
[3, 4] and obesity [39, 47], plus exercise and weight loss
interventions with proven effectiveness. Stakeholder in-
put was sought from our key collaborators: Medibank
Private and the Weight Control Clinic at Austin Health
as well as our multidisciplinary and cross-sectoral
research group. Consumers provided input into various
aspects of the trial including the resources and study
name. The rationale for the interventions is depicted in
a program logic model in Fig. 2.
All potential participants are provided with a plain lan-
guage statement which describes what is involved in each
of the study groups and the level of commitment required.
Participants are reminded of this during the online and
telephone screening process, and are excluded if they feel
they are not able to commit fully to either of the three
study groups.
Fig. 2 Logic model depicting the rationale underpinning the Exercise and Exercise plus weight management models of service delivery *Exercise
plus weight management only VLCD: very low calorie diet
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Exercise intervention
The Exercise intervention consists of educational in-
formation and links to external websites as for the
Control group (bespoke website, in addition to exer-
cise modules related only to this intervention) plus
six individual consultations with a physiotherapist via
videoconferencing over the internet (Zoom Video
Communications Inc., California USA) over 6-months
(Table 2). The physiotherapist consultations include
individualised advice on treatment options, decision
support, a structured exercise and physical activity
plan, behaviour change support, and facilitation of
other self-management strategies including pain cop-
ing skills training. Educational resources (Table 2) are
provided in hardcopy via post and electronically via
the study website. Participants are also posted three ex-
ercise resistance bands (green, red, and blue) for strength-
ening exercises and a Fitbit (Flex 2 model) to help track
and monitor physical activity.
Before their first consultation with the physiotherapist,
participants complete a pre-consultation survey asking
about their main problems and goals, a brief history of
their knee symptoms, and other health problems. The
initial physiotherapy consultation is approximately 45
min long, with follow-up consultations being approxi-
mately 20 min. Consultations are recommended to occur
in weeks 1, 3, 7, 11, 16, and 21, but the precise
timing is negotiated between each participant and
their physiotherapist.
Together with the participant, the physiotherapist
develops an individualised management plan aiming to
include the following components: i) a structured and
progressive muscle strengthening exercise program; ii) a
tailored physical activity plan to increase incidental and
general physical activity and reduce sedentary behaviour,
including a daily step goal if agreed by the participant,
and; iii) other practical self-management strategies (e.g.
activity pacing, pain coping strategies, sleep hygiene).
Table 2 Summary of resources provided to participants in the Exercise and Exercise plus weight management groups




Study website Information about OA, treatment options, exercise and physical activity, weight




6 video consultations over 6-months. Advice on treatment options, structured ex-
ercise and physical activity plan, and behaviour change support
√ √
Consultations with a dietitian 6 video consultations over 6-months. Helps participant undertake VLCD with be-
haviour change support
√
Exercise bands 3 exercise resistance bands (green, red, and blue) for strengthening exercises √ √
Activity tracker (Fitbit) To help track and monitor physical activity √ √
Plastic portion plate To help manage portion sizes √
Optifast® meal replacements 6-months’ worth of meal replacements for the VLCD √
Educational video about the
VLCD
Short video about the VLCD featuring endocrinologists and dietitian experts, and





Information about consultations, instructions on how to use Zoom
videoconferencing, and Fitbit instructions
√ √
Osteoarthritis information Understanding knee OA, common management options, weight loss, pain
coping skills, and sleep
√ √
Exercise booklet Strengthening exercise instructions and photos √ √
Knee care plan and exercise
log book
Templates to record details of management plans and completed exercises √ √
Knee replacement surgery for
osteoarthritis-related pain
Decision aid about joint replacement surgery, including the benefits and harms
of surgery
√ √
Weight management ‘how to’
guide





Workbook containing information and templates to track weight, a food diary,
tips to find a support person, identifying food triggers, planning for “at risk”
situations, overcoming barriers, changing thought patterns, and monitoring
hunger levels
√
Recipe book Recipes that are suitable for the VLCD √
Food list pocket guide List of suitable low carbohydrate ingredients to consume when on the VLCD √
OA Osteoarthritis, VLCD Very low calorie diet
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Physiotherapists use motivational interviewing principles
and techniques to develop motivation (readiness to
change) and self-efficacy as well as assist the participant
to overcome barriers to enacting their agreed manage-
ment plan. Education about OA is provided from a biop-
sychosocial perspective to facilitate confidence in ability
to manage pain. For participants who have been identi-
fied during the baseline questionnaire as having a prefer-
ence towards total joint replacement surgery in their
knee, physiotherapists discuss the benefits and harms of
surgery with participants. For those who are not yet con-
sidering surgery, information about the likelihood of
future need for surgery is discussed. During follow-up
consultations, physiotherapists review progress and
reassess goals, making modifications as required.
For the strengthening exercise program, physiothera-
pists choose from the list of exercises shown in Table 3
(based on exercises used in previous trials by the Centre
which were found to be effective [29, 48]) and aim to
prescribe 5–6 exercises, including at least one from each
category (i.e. quadriceps strengthening) and an optional
extra. The exact number of exercises, as well as sets/rep-
etitions, is negotiated between the physiotherapist and
participant. Intensity is determined using a modified
Rating of Perceived Exertion (RPE) [49], where it should
feel “hard” to “very hard” to perform a full set of each
exercises. Participants are encouraged to complete exer-
cises three times per week. For the physical activity plan,
physiotherapists encourage the participant to increase
their general and incidental levels of physical/aerobic ac-
tivity based on their individual needs and goals, as well
as their current level of activity. Participants are encour-
aged to use the provided Fitbit to record and monitor
their daily step count. Prescription of exercises/physical
activity plans is based on the clinical history and func-
tional ability of the participant. Participants are provided
with a study email they can use to contact the clinicians
between consultations if they have any questions or
encounter any issues.
During each consultation, physiotherapists complete
online treatment notes recording the call duration,
topics discussed, clinical history, personal motivators,
and details of the participant’s management plan.
Exercise plus weight management intervention
Participants who are allocated to the Exercise plus weight
management intervention receive all components of the
Exercise intervention plus 6 individual videoconferencing
consultations with a dietitian (over 6 months) who helps
the participant undertake a weight management pro-
gram involving a ketogenic very low calorie diet (VLCD)
[50]. This diet was chosen as it has been shown to lead
to greater weight loss in the short-term when compared
to low-fat diets [51, 52] and the release of ketones,
produced by the liver during fatty acid oxidation while
fasting or on a diet that restricts carbohydrates, can help
suppress appetite and contribute to further weight loss
[50]. Participants are provided with Optifast® meal re-
placements (Nestlé Health Science, Rhodes, Australia)
(or Optislim® [OptiPharm Pty Ltd., Clayton, Australia] if
unavailable or the participant is vegetarian) and add-
itional educational resources to support their weight loss
(Table 2). Participants are encouraged to lose at least
10% or more of their body weight, as this has been
associated with clinically important improvements in
pain [53, 54].
In addition to the five educational booklets provided
in the Exercise intervention, participants in the Exercise
plus weight management intervention are provided with
four additional booklets (described in Table 2). Partici-
pants are also mailed a plastic “portion plate” (https://
www.nestle.com.au/nhw/nestle-portion-plates) to help
them manage meal portion sizes. A short educational
video about the VLCD featuring endocrinologists and
dietitian experts, and a person with knee OA, is also
available on the study website.
Participants’ first consultation with the dietitian takes
place within the same week as their first physiotherapist
consultation and is approximately 45 min in duration,
with follow-up consultations approximately 20 min.
During the initial consultation, appropriate weight loss
goals, including a target weight, and a management plan
are developed. Participants are encouraged to commence
the VLCD, however they are also able to commence a
modified version of the diet (e.g. one meal replacement
only) if deemed necessary (e.g. if they do not like the
meal replacements or are having difficulty adhering).
Participants are asked to weigh themselves weekly and
record their progress in their log book. During subse-
quent consultations, dietitians discuss progress and use
motivational interviewing principles and techniques to
assist motivation [35], self-efficacy, and overcoming ob-
stacles to completing the agreed self-management plan.
Dietitians also guide participants through the resource
booklets provided, including activities to help them ad-
here to their self-management plan such as planning for
unforeseen events (e.g. eating out) and choosing a sup-
port person. Once the participant has reached their tar-
get weight, they can choose whether to transition to a
weight maintenance phase or continue with the VLCD
program and aim for further weight loss.
The VLCD involves replacing two meals, generally
breakfast and lunch, with meal replacements. Very low
calorie diet meal replacement products are formulated to
provide the adequate micronutrients (vitamins, minerals,
and metals), and come as bars, shakes, or soups in a var-
iety of flavours. On the diet, one meal (generally dinner)
comprises protein (e.g. white or red meat, fish or seafood,
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Table 3 Home exercise protocol
Maximum of 6 exercises (with progression as appropriate)
2 knee extensor strengthening exercises
1 hip abductor strengthening exercise
1 hamstring strengthening exercise
1 calf strengthening exercise
1 other exercise as appropriate






Q1. Seated knee extension (with resistance) with
5 s hold




Q2. Inner range quads over roll (with resistance)
with 5 s hold
Instruction: Put a rolled up towel under your arthritis knee. Keep the
knee cap and toes pointing toward the roof. Keeping the back of the
knee in contact with the towel, push the back of your knee down into
the towel and straighten your arthritis leg
Sit-to-stand Weight-
bearing
Q3. Sit to stand without using hands Progression: lower chair height, hover above the seat without
touching down (3 s hold), add resistance band around knees and push
outwards keeping knees over toes
Weight-
bearing
Q4. Sit to stand with more weight on involved
knee
Instruction: Take more weight by either
a) placing uninvolved further forward
b) shift both feet sideways so study leg is midline
Steps Weight-
bearing
Q5. Step-ups Progression: Increase step height
Weight-
bearing
Q6. Forward touchdowns from a step Progression: Increase step height, don’t touch floor
Weight-
bearing
Q7. Step-ups with weight Instruction: Hold 2 kg of weight either a) against chest, b) in each
hand, c) in one hand while holding for balance, or d) in backpack
Progression: Increase step height, increase weight
Weight-
bearing
Q8. Forward touchdowns from a step with
weight
Instruction: Hold 2 kg of weight either a) against chest, b) in each
hand, c) in one hand while holding for balance, or d) in backpack
Progression: Increase step height, increase weight
Wall squats Weight-
bearing
Q9. Partial wall squats for 5 s hold Progression: more weight on study side
Weight-
bearing
Q10. Split leg wall squats for 5 s hold Instruction: Step feet away from wall (about 30 cm) and move non-





Q11. Controlled partial squat with 5 s hold
Leg Sliding Weight-
bearing
Q12. Forward and backward sliding of
uninvolved leg
Instruction: Keep weight on study leg. Concentrate on keeping knee
positioned over the foot
Weight-
bearing
Q13. Forward and backward sliding of
uninvolved leg with resistance band pulling
study leg laterally
Instruction: Place loop of elastic band around involved knee and leg
of a table to provide a pull outwards on knee that you must resist by
keeping knee in line with foot.
Progression: Increase with theraband resistance – red through to black
Weight-
bearing
Q16. Sideways sliding of uninvolved leg Instruction: Keep weight on study leg. Concentrate on keeping knee
positioned over the foot
Weight-
bearing
Q17. Sideways sliding of uninvolved leg with
resistance band pulling study leg laterally
Instruction: Place loop of elastic band around study leg and leg of a
table to provide a pull outwards on knee that you must resist by
keeping knee in line with foot.






Q14. Step with study leg to about 30° knee
flexion for single leg balance
Instruction: Take a step forwards with study leg, keeping knee bent to
about 30° knee flexion. Allow uninvolved leg to lift off and practice
balancing as long as you can
Weight-
bearing
Q15. Step with study leg to about 30° knee
flexion for single leg balance with arm
movements
Instruction: Take a step forwards with involved knee, keeping knee
bent to about 30° knee flexion. Allow uninvolved leg to lift off and
practice balancing as long as you can, while raising arms out to side
and above head in an arc.






HA1. Side leg raises in standing with 5 s hold Progression: Increase theraband resistance – red through to black, add
another 5 s halfway
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eggs, or tofu) and non-starchy vegetables/salad. A small
amount (i.e. 1 tablespoon) of oil/fat is also recommended
for this meal to reduce the risk of gallstone formation. In
total, the diet contains approximately 800 cal (3280 kJ).
Transitioning off the VLCD (after target weight is
reached) is done by reintroducing foods containing car-
bohydrates and moving to only one meal replacement
per day. This transition phase usually lasts at least 2











HA3. Wall push standing on study leg for 20 s Progression: Hold weight in hand, increase the hold time
Weight
bearing
HA4. Wall push standing on study leg
positioned up to 45° knee flexion
3. Hamstring strengthening (1 exercise)
Bridging Weight-
bearing
HG1. Bridge with 5 s hold
Weight-
bearing
HG2. Split leg bridge with 5 s hold Instruction: Place feet hip-width apart, then move study leg slightly
closer toward your bottom and slightly in towards centre
Weight-
bearing
HG3. Single-leg bridge on study leg with 5 s
hold
Version A: Lift bottom. Keeping hips level, lift uninvolved leg off the
floor/bed. Hold for 5 s. Slowly lower uninvolved leg back to the floor.
Then slowly lower bottom back to floor.
Version B: Lift uninvolved knee off floor/bed. Lift bottom and take all







HG4. Hamstring curls -Standing over bench




HG5. Hamstring curls -Standing over bench
knee flexion with 5 s hold against resistance
band
Instruction: Place one end of an elastic band securely around ankle of
study knee. Place the other end of elastic around your opposite foot so






HG6. Seated knee flexion Instruction: Place one end of an elastic band securely around a stable
object (e.g. a heavy table leg). Loop the other end around the ankle of
your study leg. Keeping your opposite foot on the floor, pull against
the elastic band and bend your knee more.







HG7. Hip extension with knee bent (90°) -




HG8. Hip extension with knee straight -




HG9. Hip extension with knee straight with
resistance band - standing over bench with 5 s
hold
Instruction: Place one end of an elastic band securely around ankle of
study knee. Place the other end of elastic around your opposite foot so
you are standing on it.






C1. Double heel raises with 5 s hold
Weight-
bearing
C2. Single heel raises with 5 s hold
Weight-
bearing




C4. Double heel raises with 5 s hold over edge
of step









2. Wall push ups Progression: increase repetitions
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weeks, after which participants commence a healthy eat-
ing diet which is consistent with the principles of the
Commonwealth Scientific and Industrial Research
Organisation (CSIRO) total wellbeing diet [55] (i.e. high
protein, low glycaemic index carbohydrate, low fat). Par-
ticipants are encouraged to weigh themselves regularly
thereafter (e.g. once per week). Participants who regain
2 kg or more are advised to restart the VLCD with meal
replacements for 1–2 weeks.
Dietitians complete online consultation notes using
the same platform as physiotherapists, where they are
able to record details about agreed weight management
plans and barriers/motivators that have been discussed,
as well as record which resources/activities participants
were asked to read/complete. Dietitians and physiothera-
pists are also encouraged to communicate with each
other through their consultation notes (e.g. to flag any
important issues that the participant might be having).
To reduce the risk of loss of muscle mass during their
weight management program, physiotherapists also rec-
ommend that participants in this group complete regular
arm strengthening exercises (Table 3) in addition to
their leg strengthening program. Participants are pro-
vided with a study email they can use to contact the cli-
nicians between consultations if they have any questions
or encounter any issues.
Physiotherapist and dietitian training
Three musculoskeletal physiotherapists are employed to
deliver the intervention. Physiotherapist selection criteria
includes having experience managing people with
chronic diseases, specifically knee OA, and current regis-
tration with the Australian Health Practitioner Regula-
tion Agency. Five accredited dietitians, with at least 2
years of clinical experience and some experience assist-
ing people with weight loss, are employed to deliver the
weight management intervention. Prior to the start of
the trial, clinicians complete training in:
i) best-practice OA management: dietitians attend a
half day workshop in evidence-based management
of OA, delivered by members of the research team.
Briefly, this includes an introduction to the purpose
of the trial, OA definition, diagnosis, risk factors
and prognosis, evidence-based practice (including
education, exercise therapy, weight loss, and psy-
chological treatments), and principles of shared
decision-making and health behaviour change
techniques.
ii) motivational interviewing skills: dietitians and
physiotherapists attend a 2-day training course from
Health & Wellbeing Training Consultants, who spe-
cialise in training clinicians in motivational inter-
viewing. Case studies presented during trained are
designed to replicate potential scenarios anticipated
to arise during the trial. Following these first two
training days, clinicians conduct an initial and
follow-up video consultation with a practice partici-
pant (one per clinician) to practice using their mo-
tivational interviewing skills and recording
consultation notes. Practice consultations are audio
recorded and audited for fidelity by a member of
the research team using the Motivational Interview-
ing Treatment Integrity tool (MITI 4.2.1). Group
level feedback is provided to clinicians at a half day
workshop approximately 1 month after the initial
two training days;
iii) VLCD: dietitians attend a 1-h webinar delivered by
the research team on the specifics of the VLCD.
Physiotherapists are asked to watch the video re-
cording of the presentation.
iv) study-specific protocols: dietitians and
physiotherapists attend a 1–2 h session
(supplemented by detailed study treatment
manuals) to ensure clinicians were familiar with all
study procedures and processes. All clinicians are
provided with a hardcopy of the study manual as
well as hardcopies of all participant booklets to aid
discussions during consultations.
Treatment fidelity
After the trial commences, clinicians are able to discuss
with the research team via phone or email any issues
with delivering the intervention as planned, including
using the motivational interviewing principles. Regular
meetings are held with all clinicians and the trial team
to discuss any issues or provide feedback. All consulta-
tions are audio-recorded and a random subset will be
audited for fidelity using the MITI 4.2.1. Fidelity is also
evaluated by auditing the electronic treatment notes,
which includes details of participant management plans
(e.g. the exercises prescribed and dietary plans).
Dealing with adverse events
Expected adverse events include: i) transient increase in
knee pain or swelling due to increased exercise or phys-
ical activity; ii) feeling hungry, fatigued, fuzzy-headed,
and/or having headaches, and either diarrhoea or consti-
pation during the first week after commencing the
VLCD. Participants are advised to report any adverse
events to the study coordinator as soon as they can,
which will be documented in treatments notes and an
adverse events log. If necessary, treatment is disconti-
nued and further medical advice is arranged. Adverse
events are also collected via self-report in the 6- and 12-
month questionnaires.
Clinicians are instructed to report any adverse events to
the trial coordinator, record the event in their consultation
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notes, and refer participants to their general practitioner if
necessary. Participants are provided with a “help” email
address to contact if they have any issues with their exer-
cise/physical activity or weight management program in
between consultations. The email is monitored daily by re-
search staff and, if necessary, staff can seek further advice/
guidance from the participant’s physiotherapist and/or
dietitian.
Outcomes
Outcome measures and time points are described in
Table 4. Our primary and secondary outcome measures
are recommended and validated for knee OA trials [56,
57] and are measured at baseline, 6 and 12months.
Primary outcomes
Primary outcomes are overall average knee pain severity
in the last week measured on an 11-point numeric rating
scale (NRS), where 0 = ‘no pain’ and 10 = ‘worst pain
possible’ [58], and physical function assessed using the
physical function subscale of the Western Ontario and
McMaster Universities (WOMAC) Osteoarthritis Index
[59]. The WOMAC is a disease-specific self-report in-
strument which has demonstrated validity, reliability,
and responsiveness [60]. The physical function subscale
contains 17 questions scored from 0 to 4, giving a range
of possible scores from 0 (no dysfunction) to 68 (max-
imum dysfunction).
Secondary outcomes
Secondary outcome measures include:
i) Self-reported weight, measured in kilograms.
Participants are asked to use the same set of scales
for these measures across the time points;
ii) Physical activity, assessed using the Incidental and
Planned Exercise Questionnaire (IPEQ-W) [61];
iii) Health-related quality of life, measured using the
Assessment of Quality of Life Instrument
(AQoL-8D) [62];
iv) Global rating of change, scored on a 7-point Likert
scale for “Overall change in your study knee since
you began the study” from “much worse” to “much
better” [63];
v) Satisfaction with care, scored on a 7-point Likert
scale for “Overall satisfaction with the care you
received in this study” from “extremely unsatisfied”
to “extremely satisfied”;
vi) Self-reported appointments with an orthopaedic
surgeon;
vii) Depression, anxiety, and stress, measures on the
Depression, Anxiety, and Stress Scale (DASS-21)
[64];
viii)Self-reported total knee joint replacement and knee
arthroscopy surgery;
ix) Willingness to undergo surgery, measured on a 5-
point Likert scale ranging from “definitely not will-
ing” to “definitely willing”.
Descriptive data
At baseline, descriptive data is collected, including: i)
age; ii) gender; iii) height and weight; iv) country of
birth; v) postal code; vi) Aboriginal or Torres Strait Is-
lander Heritage; vii) education level; viii) current em-
ployment status; ix) duration of symptoms; x) length of
time since first visit to a doctor for knee pain; xi) previ-
ous history of knee arthroscopy and arthroplasty; xii)
pain in other parts of the body; xiii) expectation of treat-
ment outcomes, and; xiv) medication use.
Determinants
i) Self-efficacy for managing arthritis symptoms,
measured using the Arthritis Self-Efficacy Scale
[65];
ii) Self-efficacy for eating control, measured using the
Weight Efficacy Lifestyle Questionnaire [66];
iii) Attitudes towards self-management, measured using
the Patient Activation Measure (PAM-13) [67];
iv) Treatment beliefs about arthroplasty, using the
Treatment beliefs in knee and hip OsteoArthritis
(TOA) questionnaire – Arthroplasty subscale [68];
v) Fear of movement, measured using the Brief Fear of
Movement Scale for osteoarthritis [69].
Additional measures
Economic data: assessed by self-reported medication use
and healthcare costs (regarding the use of health ser-
vices), quality-adjusted life years (QALY), cost-
effectiveness ratio (calculated using predictions of health
care costs and QALYs), and work productivity (using the
World Health Organisation Health and Work Perform-
ance Questionnaire [70]). Knee surgery costs will be
obtained by linking to Medibank data.
Adverse events: any undesirable clinical occurrence,
whether considered to be treatment-related or not, that
includes a clinical sign, symptom, or condition, are self-
reported in questionnaires and recorded by the clinician
during the consultation. Participants are asked to pro-
vide details on the nature of the event, how long it lasted
for, and what action they took.
Adherence: assessed by recording the number of
consultations received from the physiotherapist and/or
dietitian. Adherence to prescribed exercise and physical
activity programs is self-reported by the participant via
questionnaire, being scored on an 11-point NRS (0 = not
at all and 10 = completely as instructed). Adherence to
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Table 4 Summary of measurements to be taken
Domain Data collection instrument Time points
Baseline 6 M 12
M
Descriptive data
Age, gender, height, body
mass index
✓










5-point ordinal scale ✓
Primary outcome measures
Average knee pain in past
week
11-point NRS ✓ ✓ ✓
Physical function in past 48 h WOMAC physical function subscale ✓ ✓ ✓
Secondary outcome measures
Weight Self-reported ✓ ✓ ✓
Physical activity IPEQ-W questionnaire ✓ ✓ ✓
Health-related quality of life AQoL-8D questionnaire ✓ ✓ ✓
Perceived change since
baseline
Overall change, 7-point ordinal scale ✓ ✓
Change in pain, 7-point ordinal scale ✓ ✓
Change in function, 7-point ordinal scale ✓ ✓
Change in physical activity, 7-point ordinal scale ✓ ✓
Satisfaction with care 7-point ordinal scale ✓ ✓
Appointment with
orthopaedic surgeon
Yes/No ✓ ✓ ✓
Depression, anxiety, and
stress
DASS-21 ✓ ✓ ✓
Surgery performed Self-reported TKJR and arthroscopy ✓ ✓
Willingness to undergo
surgery
5-point ordinal scale ✓ ✓ ✓
Other measures
Health economic data Quality adjusted life years ✓ ✓ ✓
Self-reported medication use ✓ ✓ ✓
Self-reported use of health services/co-interventions ✓ ✓ ✓
Cost-effectiveness ratio ✓ ✓
Work productivity (WHO HPQ Short Form) ✓ ✓ ✓
Adherence Number of consultations with physiotherapista ✓
Number of consultations with dietitianb ✓
Duration of consultations with physiotherapista ✓
Duration of consultations with dietitianb ✓
Self-rated adherence to strengthening exercisea/ physical activitya/weight
managementb, 11-point NRS
✓
Perceived usefulness Times accessed website, 5-point ordinal scale ✓ ✓
Usefulness of website, 11-point NRS ✓
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the weight management plan, if applicable, is also self-
reported and scored on a similar 11-point NRS.
Perceived usefulness of treatment components: assessed
by self-report with response options ranging from 0 =
“not at all” to 10 = “extremely useful”. Usefulness ques-
tions relate to the information on the website, consulta-
tions with the physiotherapist and/or dietitian, resource
booklets, Fitbit, VLCD, strengthening exercise program,
and physical activity plan. Participants will also be asked
how many times they accessed the website in the last 6-
months (5-point scale ranging from “never” to “> 10
times”) and how easy it was for them to use the
videoconferencing software (11-point NRS ranging
from 0 = “not at all easy” to 10 = “extremely easy”).
Long-term surgical rates: via linkage with the data rou-
tinely collected by Medibank Private, and will include
the number of individuals who had a knee arthroscopy
and/or arthroplasty intervention at 2 and 5 years after
baseline. These findings will be reported separately from
the main trial outcomes.
Trial sample size
The primary outcomes of this trial include changes in
pain (NRS) and physical function (WOMAC) over 6
months and the intervention will be considered benefi-
cial if it changes either one or both of the primary
outcomes. A Cochrane Review shows that exercise has a
moderate effect size for pain and function in knee OA
[10]. Calculations thus assume an effect size between the
least-performing treatment group (presumed to be the
Exercise group) and the control group of 0.4. Given that
the effect size between two treatments will be less than
between treatment and control, we assumed an effect
size of 0.3 between the Exercise group and the Exercise
plus weight management group. We chose 0.3 because
any smaller effect is unlikely to be clinically relevant or
cost-effective to implement in real-world settings given
the considerable expense of the weight management
program relative to the exercise components of this
combined intervention. Calculations also assume a cor-
relation between baseline and follow-up measurements
of 0.4, power 80, 15% loss to follow-up (based on our
previous research [71, 72]), and two-sided significance
level of 0.05. Based on these calculations we require 173
participants in each treatment group, and 69 participants
in the control group arm, giving a total sample size of
415 participants.
There are different levels of clustering for each of the
three groups; in the Exercise group, participants are clus-
tered by physiotherapist, in the Exercise plus weight
management group, people are clustered by physiother-
apist and dietitian, and in the control group, there is no
Table 4 Summary of measurements to be taken (Continued)
Domain Data collection instrument Time points
Baseline 6 M 12
M
Usefulness of physiotherapy consultationsa 11-point NRS ✓
Usefulness of dietitian consultationsb 11-point NRS ✓
Usefulness of educational resourcesa 11-point NRS ✓
Usefulness of Fitbita 11-point NRS ✓
Usefulness of ketogenic dietb 11-point NRS ✓
Usefulness of strengthening exercise programa 11-point NRS ✓
Usefulness of physical activity plana 11-point NRS ✓
Video software ease of usea 11-point NRS ✓
Harms Adverse events ✓ ✓
Determinants Self-efficacy for symptom control (ASES) ✓ ✓ ✓
Self-efficacy for eating (WELQ) ✓ ✓ ✓
Attitudes towards self-management (PAM-13) ✓ ✓ ✓
Treatment beliefs about arthroplasty (TOA) ✓ ✓ ✓
Fear of movement (BFMS) ✓ ✓ ✓
Long-term surgical rates Number who have had arthroscopy/arthroplasty 24months and 60
months
NRS Numeric rating scale, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, IPEQ-W Incidental and Planned Exercise Questionnaire, AQoL-
8D Assessment of Quality of Life Instrument, DASS Depression, Anxiety, and Stress Scale, TKJR Total knee joint replacement, WHO HPQ World Health Organization
Health and Work Performance Questionnaire, ASES Arthritis Self-efficacy Scale, WELQ Weight Efficacy Lifestyle Questionnaire, PAM Patient Activation Measure, TOA
Treatment beliefs in knee and hip OA – arthroplasty subscale, BFMS Brief Fear of Movement Scale for osteoarthritis
ameasured in Exercise and Exercise plus weight management groups only
bmeasured in Exercise plus weight management group only
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clustering. Given the geographical and demographic
spread of participants, we expect that the intra-cluster
correlation of outcomes treated by the same dietitian or
physiotherapist to be of the order of 0.01. Modifying the
formulae [73] to allow for correlations between baseline
and follow-up measurements, and assuming that there
are five dietitians delivering the Exercise plus weight
management treatment, the effect size that can be de-
tected between the Exercise and the Exercise plus weight
management groups with 80% power given the originally
calculated sample size increases slightly to 0.32.
Analysis
We will use intention-to-treat analyses, using multiple
imputation to account for missing data and details on
the imputation will be reported [74]. Participants will be
included in their randomised treatment groups regard-
less of their post-randomisation behaviour. P values less
than 0.05 will be considered significant. Outcomes (pri-
mary, secondary, and determinants) will be compared
between groups as follows: i) Exercise vs Exercise plus
weight management; ii) Exercise vs control, and; iii) Exer-
cise plus weight management vs control. For continuous
data, mean differences in change over time between
these groups will be estimated using linear regression
models fit to data from both follow-up time points, with
random effects for participants, and accounting for clus-
tering by physiotherapist and dietitian in the Exercise
and Exercise plus weight management groups. Models
will be adjusted for the stratification variable (history of
knee surgery) and values of the outcome at baseline.
Terms for time and treatment will be included, with an
interaction between the two. Regression assumptions
will be assessed using standard diagnostic plots. For bin-
ary outcomes, logistic regression models will be fit using
generalised estimating equations to account for cluster-
ing, with risk differences and 95% confidence intervals
calculated. This will include a comparison of the propor-
tion of participants in each group whose improvement
meets or exceeds the minimal clinically important differ-
ence for each of the primary outcomes. For ordinal out-
comes, proportional odds models will be fit similarly.
Multinominal models will be applied if the assumption
of proportional odds is not valid. To assess the sensitiv-
ity of the results for the primary outcomes in situations
in which the outcomes are missing not at random, we
will apply a pattern-mixture approach that involves fit-
ting regression models that adjust for departures from
the missing at random assumption [75].
Economic evaluations will assess and compare the
cost-effectiveness of the interventions. This will involve
analysis of: i) cost per extra person with a clinically sig-
nificant improvement in pain (measured as 1.8 point re-
duction on the pain score) and function (6 unadjusted
WOMAC units), and; ii) per quality-adjusted life years
(QALYs) gained for the intervention compared to con-
trol at 12 months. QALYs will be calculated based on
utility scores using the AQoL-8D at baseline and 12
months. The difference in health care usage and prod-
uctivity lost between baseline and 12 months will be
compared for intervention and control groups. The asso-
ciation between utility gains on the AQoL-8D and prod-
uctivity will also be compared between the intervention
and control groups.
To evaluate the longer-term effects of the Exercise and
Exercise plus weight management interventions on total
knee joint replacement and knee arthroscopy surgical
rates, logistic regression models for surgery will be fit
using generalised estimating equations to account for
clustering by physiotherapist and dietitian, with treat-
ment effects summarised using risk differences and 95%
confidence intervals. The stratifying variable of history
of knee surgery will be adjusted for.
To evaluate whether there is a relationship between
amount of weight loss and changes in pain and/or func-
tion, linear regression models for changes in pain and
outcome will be fit and will include a term for weight
lost at 6 and 12 months (as percentage of baseline
weight), adjusting for baseline level of the outcome,
assigned treatment group, and stratifying variables.
Demographic variables thought to affect both weight loss
and outcomes levels, including age and sex, will also be
included in the model. Fractional polynomial terms for
weight lost will be assessed to investigate if the relation-
ship between outcomes and weight loss is non-linear.
Standard diagnostic plots will be used to assess regres-
sion assumptions. We will also evaluate whether there is
a relationship between adherence to exercise and
changes in pain and/or function by estimating a
complier-average causal effect using a two-stage least
squares approach [76].
Finally, we will conduct exploratory analyses to investi-
gate whether the relative effects of each intervention on
change in each of the primary outcomes is moderated
by: i) expectation of treatment effects; ii) sex; iii) pain
self-efficacy; iv) BMI; v) employment situation; vi) his-
tory of knee surgery (contralateral total knee joint re-
placement surgery and/or knee arthroscopic surgery);
vii) self-efficacy for eating control, and; viii) depression.
These moderators were selected based on previous re-
search and/or theoretical plausibility (Table 5). Models
will include terms for treatment, the moderator vari-
ables, and an interaction between the two. Fractional
polynomials will be included for the continuous modera-
tors [88]. The estimated effects of treatment and 95%
confidence intervals will be presented for each moder-
ator, with visual representations included for continuous
moderators.
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Ethics
Ethical approval has been obtained from the University
of Melbourne Human Research Ethics Committee
(HREC No. 1750443). All participants will provide writ-
ten informed consent. The funding agency (Medibank)
will be responsible for marketing the study to support
recruitment, by making the study known (via email, let-
ters, articles, newsletters and social media) to potentially
eligible members. All marketing material viewed by
member will include a statement that their involvement
in the study will not affect their relationship or policy
with Medibank. Medibank will not be involved in statis-
tical analysis.
Discussion
With the rapidly rising burden of knee OA, there is an
urgent need for interventions that improve outcomes
and that are also widely accessible to people in rural,
regional, and metropolitan communities [89]. Although
the effectiveness of exercise therapy on pain and func-
tion is well-established, there is relatively limited robust
evidence about the additional benefits of weight loss in
people with knee OA [4].
This trial will be the first to investigate the clinical-
and cost-effectiveness of a remotely delivered service
combining dietary weight management and exercise,
compared to a service involving exercise only and to an
online information-only control group. Such a service
has the potential to be a low-cost and accessible way in
which people with OA can receive care, thus potentially
increasing uptake of recommended management
methods, like weight loss and exercise. Findings from
this study will inform healthcare providers about the ef-
fects of incorporating weight loss components into exer-
cise interventions. Moderator analyses using data from
this study will also allow us to determine whether
Table 5 Overview of selected demographic and clinical moderators
Selected moderator variables Justification
Expectation of treatment effects Based on evidence that greater treatment expectations are associated with more favourable outcomes in people
with osteoarthritis [77–79].
Hypothesis: Participants in the intervention groups who have greater treatment expectations will report greater
improvement in primary outcomes than those who have lower treatment expectations (relative to control group).
Sex Based on evidence that being male is associated with better outcomes in pain and physical function after
supervised strengthening exercises [80] and evidence from a review that being female is associated with greater
weight loss intentions [81].
Hypothesis: Participants in the intervention groups who are male will report greater improvement in primary
outcomes than those who are female (relative to control). Participants in the Exercise plus weight management
group who are female will report greater improvement in primary outcomes than those who are male (relative to
Exercise group).
Pain self-efficacy Based on evidence that higher self-efficacy associated with better outcomes in pain and quality of life after super-
vised neuromuscular exercise [82], and greater improvements in pain after and internet-delivered exercise and edu-
cation program [83].
Hypothesis: Participants in the intervention groups who have higher self-efficacy at baseline will report greater im-
provement in primary outcomes than those who have lower self-efficacy (relative to control group).
Body mass index Based on evidence that obesity is associated with better outcomes in quality of life after supervised aquatic
exercise [84] and evidence from a review that higher initial BMI is associated with greater weight loss [85].
Hypothesis: Participants in the intervention groups who have a higher BMI will report greater improvement in
primary outcomes (relative to control) than those who have a lower BMI. Participants in the Exercise plus weight
management group who have a higher BMI will report greater improvement in primary outcomes than those with
a lower BMI (relative to Exercise group).
Employment situation Based on evidence that being employed associated with greater improvements in pain after an internet-delivered
exercise and education program [83].
Hypothesis: Participants in the intervention groups who are employed will report greater improvement in primary
outcomes than those who are not employed (relative to control group).
History of knee surgery Chosen based on theoretical plausibility that knee surgical experience could affect expectations of outcomes and
motivation
Hypothesis: Participants in the intervention groups who have a history of knee surgery will report less improvement
in primary outcomes than those without (relative to control group).
Self-efficacy for eating control Based on evidence from a review that better control of over-eating and dietary restraint is associated with weight
loss and maintenance [86, 87].
Hypothesis: Participants in the Exercise plus weight management group who have higher self-efficacy for eating con-
trol will report greater improvement in primary outcomes than those with lower self-efficacy for eating control (rela-
tive to Exercise group and to control group).
Depression Based on evidence that fewer depressive symptoms is associated with better outcomes in pain and physical
function after supervised strengthening exercises [80].
Hypothesis: Participants in the intervention groups who have more depressive symptoms at baseline will report less
improvement in primary outcomes than those who have less depressive symptoms (relative to control group).
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specific sub-groups of participants are more likely to re-
spond to these remotely delivered services, which will
allow health service providers to better target interven-
tions to those that would benefit most. Qualitative ex-
plorations will provide insight into the feasibility and
viability of implementing similar weight management
programs into private and public healthcare settings
from the perspective of both the participants receiving
care, as well as the clinicians involved in delivering it.
A potential limitation of this trial is the targeted sam-
ple of participants, including only those who are Medi-
bank Private members with a level of membership that
includes arthroplasty surgery. This may potentially limit
the generalisability of our findings, however, Medibank
Private is one is one of the largest providers of private
health insurance in Australia, and participants will be re-
cruited Australia-wide to attempt to maximise the gen-
eralisability of the cohort.
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